Virtual Reality Brain Imaging for Drug Simulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for imaging the brain, particularly for neurodegenerative disease research, are limited by the difficulty in tracking the progression of neurodegenerative disorders in living organisms and the slow drug development process due to the complexity of the brain and lack of effective treatment strategies.
Innovation Solution
A method using virtual reality to create a three-dimensional image of the brain based on MRI data, simulating drug administration, diffusion, and neuronal activity, allowing for real-time analysis and determination of treatment protocols.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If traditional imaging methods (MRI, PET, SPECT) are used at specific time points, then structural information of the brain can be obtained, but the dynamic progression of neurodegenerative disorders cannot be tracked
Solution Approach 1:
The patent pre-processes and integrates multiple imaging modalities (MRI, PET, SPECT) into a unified 3D virtual reality model before actual observation. This preliminary integration of structural, metabolic, and functional data allows dynamic tracking without requiring repeated separate imaging procedures, thus preventing information loss while minimizing time loss.
Solution Approach 2:
The patent creates a virtual copy of the brain in 3D space that replicates all imaging data. This virtual model can be manipulated and observed dynamically without requiring physical re-imaging, thus preserving dynamic progression information while eliminating the time cost of repeated scans.
2Reliability
If repetitive trial and error cycles are used for drug development, then treatment effectiveness can be tested, but the drug development process becomes slow and challenging
Solution Approach 1:
The patent performs preliminary drug delivery simulations in the virtual brain model before actual clinical trials. By pre-testing various drug delivery scenarios, dosages, and pathways in the virtual environment, the system identifies promising treatment approaches that can then be tested in fewer real-world trials, thus maintaining reliability while accelerating productivity.
Solution Approach 2:
The patent uses a virtual copy of the brain to test drug effects repeatedly without ethical or practical constraints. This virtual testing ground allows extensive trial and error cycles to be performed quickly and cheaply, identifying effective treatments before committing to slow and expensive clinical trial processes.
3Manufacturing precision
If detailed brain imaging and drug simulation are performed, then treatment protocols can be optimized, but computational complexity and processing requirements increase
Solution Approach 1:
The patent divides the complex brain model into segmented regions based on the integrated imaging data. This segmentation allows drug diffusion and neuronal stimulation simulations to be performed in manageable zones rather than attempting to model the entire brain at once, thus achieving high treatment protocol precision while reducing computational complexity through divide-and-conquer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables more effective simulation and analysis of drug delivery and neuronal activity, facilitating the development of treatment protocols and potentially speeding up the drug development process for neurodegenerative diseases.
Implementation Method 1
a plurality of three-dimensional images captured by magnetic resonance imaging (MRI)
Implementation Method 2
displaying a simulated diffusion of the drug in three-dimensional virtual reality image of the brain of the living patient
Data Source
AI summary
A method for imaging the brain of a living patient includes creating and displaying an unconstrained 3D virtual reality image of the brain of the living patient based on a plurality of 3D images captured by magnetic resonance imaging (MRI). An administration of a drug is simulated into brain tissue. The simulation includes displaying a simulated diffusion of the drug in 3D VR image of the brain; displaying simulated brain tissue uptake of the drug in the 3D VR image of the brain; displaying a simulated stimulation of individual neurons in the 3D VR image of the brain; and analyzing a simulated activity of the individual neurons based on at least one predetermined property of the drug. The method further includes determining a brain treatment protocol based at least in part on the simulated administration of the drug into the brain.